GovTwin / Companies / Beximco Pharmaceuticals

Beximco Pharmaceuticals

DSE: BXPHARMA

Pharmaceuticals · Beximco Group

Beximco Pharmaceuticals is a major Bangladeshi drug manufacturer and the pharmaceutical arm of the Beximco Group, one of the country's largest conglomerates. It produces branded generic medicines for the domestic market and exports.

Business: Manufacturing and marketing of finished generic formulations, intravenous fluids, inhalers and specialty products, plus pharmaceutical exports to regulated and semi-regulated markets.

Market data

Market capitalisation

54,470 mn BDT

Paid-up capital

4,461 mn BDT

Outstanding shares

446,112,089

Last price

122.0 BDT

Listed

1986

Market category

A

Source: Dhaka Stock Exchange, fetched 2026-05

Policy exposure

Conglomerate ownership and group-level governance risk Being part of a large, diversified group exposes the listed pharma entity to related-party and group-financial-health risks that bear on minority-shareholder protection and disclosure rules. Source: analysis

Bank-group nexus and credit exposure Conglomerate groups with large bank borrowings raise systemic concerns about concentrated lending and non-performing-loan exposure that the central bank monitors. Source: analysis

LDC graduation and pharmaceutical patent transition Loss of the TRIPS patent exemption after graduation will reshape the generics export strategy of major producers, a key sector-transition policy issue. Source: analysis